Unknown

Dataset Information

0

Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus.


ABSTRACT: Bronchiolitis obliterans syndrome (BOS), caused by lung allograft-derived mesenchymal cells' abnormal proliferation and extracellular matrix deposition, is the main cause of lung allograft rejection. In this study, a mild one-step ionotropic gelation method was set up to nanoencapsulate the everolimus, a key molecule in allograft organ rejection prevention, into hyaluronic acid-decorated chitosan-based nanoparticles. Rationale was the selective delivery of everolimus into lung allograft-derived mesenchymal cells; these cells are characterized by the CD44-overexpressing feature, and hyaluronic acid has proven to be a natural selective CD44-targeting moiety. The optimal process conditions were established by a design of experiment approach (full factorial design) aiming at the control of the nanoparticle size (?200 nm), minimizing the size polydispersity (PDI 0.171 ± 0.04), and at the negative ? potential maximization (-30.9 mV). The everolimus was successfully loaded into hyaluronic acid-decorated chitosan-based nanoparticles (95.94 ± 13.68 ?g/100 mg nanoparticles) and in vitro released in 24 h. The hyaluronic acid decoration on the nanoparticles provided targetability to CD44-overexpressing mesenchymal cells isolated from bronchoalveolar lavage of BOS-affected patients. The mesenchymal cells' growth tests along with the nanoparticles uptake studies, at 37 °C and 4 °C, respectively, demonstrated a clear improvement of everolimus inhibitory activity when it is encapsulated in hyaluronic acid-decorated chitosan-based nanoparticles, ascribable to their active uptake mechanism.

SUBMITTER: Chiesa E 

PROVIDER: S-EPMC6121415 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus.

Chiesa Enrica E   Dorati Rossella R   Conti Bice B   Modena Tiziana T   Cova Emanuela E   Meloni Federica F   Genta Ida I  

International journal of molecular sciences 20180807 8


Bronchiolitis obliterans syndrome (BOS), caused by lung allograft-derived mesenchymal cells' abnormal proliferation and extracellular matrix deposition, is the main cause of lung allograft rejection. In this study, a mild one-step ionotropic gelation method was set up to nanoencapsulate the everolimus, a key molecule in allograft organ rejection prevention, into hyaluronic acid-decorated chitosan-based nanoparticles. Rationale was the selective delivery of everolimus into lung allograft-derived  ...[more]

Similar Datasets

| S-EPMC7490593 | biostudies-literature
| S-EPMC5085145 | biostudies-other
| S-EPMC9877355 | biostudies-literature
| S-EPMC9304880 | biostudies-literature
| S-EPMC5003084 | biostudies-literature
| S-EPMC6401931 | biostudies-literature
| S-EPMC6766933 | biostudies-literature
| S-EPMC6116812 | biostudies-other
| S-EPMC3638880 | biostudies-literature
| S-EPMC5413407 | biostudies-literature